Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours Β· Estimated delivery Sep 30 - Oct 5
SMGT-GLP-1, with its unique mechanism of action, has already achieved significant results in diabetes treatment and weight management
While the clinical impact of GLP-1s on approved indications (e.g., obesity, diabetes, cardiovascular risk) and adjacent indications is being studied extensively in clinical trials, there is limited scientific literature on GLP-1 use, efficacy or persistence outside of clinical trial settings
A liver substudy, an earlier Phase 2 secondary finding, showed the drug cleared fatty liver in most people on the higher doses, and there are programs running in sleep apnea, chronic kidney disease, and low back pain
Before a brand-name GLP-1 medication is approved, it goes through extensive clinical trials to confirm that it works the way its supposed to, is dosed appropriately and has clearly understood side effects
US$ 28.66
US$ 28.69
US$ 25.64
US$ 28.45
US$ 21.87
